I agree with you moneynow. Guidance and earnings not impressive. Short squeeze? I guess that may be the reason. The % ratio of shorts isn't too high. But with 3M shorts on a thinly traded stock, well that could be enough to squeeze.
I was waiting for it to break out above 52 before shorting, which it just did.
ZUMZ is a stock that many love to hate. In the past, me included. I have stayed away from ZUMZ for a while. Revisiting it now, It is pretty surprising how its PE, Foward PE, PEG are now in line with real businesses and their PPS.
PE in the 16s, Forward PE in the 11s ?? ZUMZ looks attractively priced to me. I bought at 25, so I am a little underwater at current price 24.11. But I think that is still a decent price once the day traders get done with this.
I wonder if other brokers besides Fidelity are allowing. I would think volume should be even higher than it is.
With a Forward P/E now at 15.17 and PEG Ratio at 1.00, SWI is now at a very attractive entry point. The low daily volume explains the exaggerated move this morning.
Also, SWI is trading 20-30% below NEW target prices.
I almost pulled the trigger last night in AH around 42. Glad I waited.
TriNet shares to be down more than 15%, says JPMorgan (no s##t)
JPMorgan expects shares of TriNet to be down more than the 2015 EBITDA guidance cut of 15% given management credibility concerns following the company's Q2 miss. It lowered its price target for shares to $24 from $39 but keeps an Overweight rating on the stock. TriNet continues to post solid underlying unit growth, JPMorgan points out.
TNET has a low float and is also thinly traded (typically). This contributed to the exaggerated move at the open.
Fluidigm weakness a buying opportunity, says Leerink
Mizuho maintains neutral rating but Fluidigm price target lowered to $15
This down draft in KPTI appears to be a great entry point. AML have a high incident for sepsis in the first place. The 8 patients who did get sepsis could be in the normal range. Changing dosage in clinical trial is pretty typical.
Another reason to buy is Blueberry showed up. Once this ambulance chaser shows up, it is a sure sign to go the opposite. lol
yep, the Bid/Ask sizes are pretty small. So someone is playing with this stock until they get the price they want.
ummm, just read. What was it specifcally you were pointing to.? Seems in line with earlier announcment.
A stock like ANFI with a low daily trading volume and low float is easy for MMs to manipulate. Throw a few scares out there and bingo, shorts get there way.
Beat earnings by .02 and the revenue increase was a very nice beat. This is a pleasant surprise. Movement over the last month implied a miss. It will be interesting to see how this mover tomorrow.
TAPM finally moved out of a tight trading range and popped above a couple of "weak" resistance points.
Looking at the 1 year chart, no serious resitance before .80. It will be interesting to see what happens in the next couple of weeks.